Neil Dahiya

Neuvotion has revealed an expansion of their partnership with Intelligent Product Solutions (IPS) as they work towards launching their neurostimulation product. This partnership includes a private investment from IPS’s parent organization, Forward Industries, intended to accelerate the introduction of their […]

BiVacor revealed today that it has successfully concluded the initial phase of an FDA-sanctioned early feasibility study (EFS) for its Total Artificial Heart (TAH). In this phase, the BiVacor TAH was implanted in five patients between July and November 2024,

ElectroCore, a company listed on the Nasdaq under the ticker ECOR, has announced its intentions to purchase NeuroMetrix, also traded on Nasdaq under NURO, along with its Quell neuromodulation technology. About the Quell Platform: NeuroMetrix has developed the Quell system—a

Moon Surgical revealed the induction of medtech expert Chris Toth as an independent board director. Toth, possessing over two decades of experience in advancing and managing commercial operations, brings deep knowledge in business acceleration. Currently, he holds the position of

CardioFocus recently announced the successful completion of the first set of treatments in the OptiShot pulsed-field ablation system study. This work is part of the VISION AF clinical trial, aiming to assess OptiShot’s efficiency in addressing paroxysmal AFib. Dr. Vivek

Smith+Nephew (NYSE: SNN) has officially secured FDA clearance for its innovative stemless anatomical total shoulder implant, part of the Aetos system. This new product answers the rising demand for anatomical total shoulder replacements, providing a compact solution that allows for

JenaValve shared that it has successfully conducted the initial patient procedure to join a registry dedicated to its Trilogy transcatheter heart valve (THV) system. JENA-VAD, serving as a forward-looking, multi-center, single-arm clinical registry, is a segment of the ALIGN-AR study.

BD (NYSE: BDX) Reaches Resolution with SEC Over Alaris Infusion System Investigation BD, the company headquartered in Franklin Lakes, New Jersey, has confirmed an agreement with the U.S. Securities and Exchange Commission (SEC) to conclude an inquiry into its Alaris

Flow Medical has successfully secured $5 million in an oversubscribed seed financing round, as stated by the thrombolysis catheter innovators today. The round builds on a previously announced $2 million contribution from friends and family, along with new capital from

Merit Medical Systems (Nasdaq:MMSI) has announced that Joseph C. Wright, its current President, will step down from his position, effective January 3, 2025. The organization, based in South Jordan, Utah, specializes in producing disposable medical devices, and attributed Wright’s decision